Zimmer Biomet (ZBH) PT Raised to $169 at UBS
Tweet
Share
E-mailGet Alerts ZBH Hot Sheet
Price: $87.57 +0.55%
Rating Summary:
18 Buy, 25 Hold, 4 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 14 | New: 26
Rating Summary:
18 Buy, 25 Hold, 4 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 14 | New: 26
Join SI Premium – FREE
UBS raised its price target on Zimmer Biomet (NYSE: ZBH) to $169.00 (from $165.00) while maintaining a Buy rating.
You May Also Be Interested In
- CaixaBank SA (CABK:SM) (CAIXY) PT Raised to EUR12.90 at Goldman Sachs
- Outdoor Holding (POWW) PT Raised to $2.75 at Roth/MKM, reiterates Top Pick
- American Airlines (AAL) PT Raised to $21 at UBS Ahead of Q2 Earnings
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
